emerg
highli
pathogen
avian
influenza
viru
hpaiv
subtyp
sinc
result
larg
outbreak
poultri
transmiss
poultri
human
mostli
southeast
asia
also
sever
european
countri
effect
diagnosi
control
measur
essenti
manag
hpaiv
infect
develop
rapid
diagnost
test
panel
murin
monoclon
antibodi
mab
influenza
viru
subtyp
gener
eleven
mab
produc
characteris
accord
reactiv
indirect
sandwich
elisa
western
blot
differ
subtyp
repres
past
virus
current
circul
ten
mab
react
strongli
haemagglutinin
ha
protein
virus
wherea
one
mab
react
protein
target
ha
protein
epitop
seem
conform
one
hybridoma
clone
bind
linear
epitop
protein
one
specif
mab
react
hpaiv
immunofluoresc
test
two
antibodi
neutralis
virus
basi
result
set
seven
mab
appropri
develop
diagnost
test
gener
mab
sandwich
elisa
develop
recognis
strain
test
influenza
virus
elisa
littl
ha
unit
ngml
detect
surpass
elisa
test
novel
reagent
potenti
improv
significantli
avail
rapid
antigen
detect
system
influenza
viru
subtyp
infect
bird
thought
limit
zoonot
potenti
public
health
signific
emerg
spread
new
asian
lineag
viru
assumpt
chang
dramat
viru
abl
infect
broad
spectrum
nonavian
speci
includ
human
capua
alexand
virus
genu
influenza
famili
orthomyxovirida
group
haemagglutinin
ha
subtyp
accord
reactiv
serolog
test
haemagglutin
inhibit
test
nine
neuraminidas
na
subtyp
eight
singlestrand
rna
segment
influenza
viru
genom
encod
viral
protein
accord
virul
avian
influenza
virus
categoris
two
group
highli
pathogen
avian
influenza
virus
hpaiv
caus
high
mortal
approach
chicken
low
pathogen
avian
influenza
virus
lpaiv
caus
mild
respiratori
diseas
poultri
deregt
et
al
alexand
infect
hpaiv
gener
caus
strain
subtyp
result
high
econom
loss
poultri
industri
retrospect
studi
shown
domest
poultri
play
substanti
role
gener
novel
influenza
viru
strain
capac
cross
speci
barrier
capua
alexand
yang
et
al
recent
hpaiv
viru
transmit
occasion
fowl
human
humantohuman
transmiss
famili
cluster
report
august
human
case
laboratori
confirm
fatal
outcom
laboratori
diagnosi
influenza
essenti
surveil
treatment
vaccin
develop
petric
et
al
diagnosi
hpaiv
gener
includ
convent
viru
cultur
follow
serolog
differenti
also
may
includ
rapid
costeffect
technolog
allow
detect
subtypespecif
viral
antigen
nucleic
acid
diagnosi
hpaiv
infect
human
recommend
rtpcr
realtim
rtpcr
molecular
method
rapid
antigen
detect
system
socal
pointofcar
test
viru
cultur
commerci
avail
rapid
antigen
detect
system
principl
use
point
care
even
untrain
personnel
without
laboratori
equip
provid
result
within
min
howev
pointofcar
test
gener
later
flow
test
vari
greatli
sensit
specif
laboratori
confirm
reactiv
sampl
requir
beigel
et
al
petric
et
al
chan
et
al
cui
tong
direct
comparison
sensit
specif
avail
pointofcar
test
difficult
due
variabl
condit
test
evalu
preliminari
result
show
poor
clinic
sensit
commerci
rapid
antigen
detect
system
diagnosi
avian
influenza
ai
patient
furthermor
test
detect
sever
subtyp
influenza
virus
therefor
chotpitayasunondh
et
al
chan
et
al
ghebremedhin
et
al
suggest
test
use
situat
high
risk
avian
influenza
high
viral
load
expect
later
flow
elisa
test
recommend
surveil
program
charlton
et
al
howev
need
specif
sensit
rapid
antigen
detect
system
monoclon
antibodi
mab
compar
polyclon
antibodi
pab
abl
increas
specif
sensit
immunolog
assay
system
yang
et
al
import
select
detect
virus
antibodi
test
vaccin
efficaci
studi
might
possibl
therapeut
use
du
et
al
oh
et
al
studi
newli
develop
murin
mab
influenza
viru
subtyp
analys
reactiv
immunochem
test
system
abil
neutralis
influenza
viru
subtyp
suitabl
tool
develop
improv
pointofcar
test
mdck
cell
propag
eagl
minim
essenti
medium
emem
invitrogen
paisli
uk
supplement
foetal
bovin
serum
fb
pan
aidenbach
germani
glutamin
paa
pasch
austria
nonessenti
amino
acid
paa
thirti
influenza
virus
repres
ha
subtyp
includ
isol
repres
clade
two
isol
influenza
b
viru
tabl
grown
either
embryon
chicken
egg
specif
pathogenfre
spf
egg
lohmann
tierzucht
cuxhaven
germani
mdck
cell
stock
isol
influenza
b
virus
produc
mdck
monolay
wherea
subtyp
propag
embryon
egg
viru
harvest
either
allanto
fluid
cell
supernat
latter
cell
scratch
centrifug
cell
supernat
g
multifug
sr
thermo
fisher
scientif
langenselbold
germani
min
room
temperatur
supernat
allanto
fluid
collect
inactiv
betapropiolacton
ferak
berlin
berlin
germani
store
c
inactiv
perform
icecold
dilut
betapropiolacton
trishcl
ph
viru
materi
mix
thoroughli
betapropiolacton
ph
mix
adjust
valu
solut
store
c
overnight
follow
incub
c
h
inactiv
verifi
infect
cell
egg
neither
cytopath
effect
cell
cultur
ha
activ
allanto
fluid
supernat
observ
four
passag
furthermor
taqmanpcr
neg
sampl
prove
inactiv
viru
inactiv
virus
use
elisa
western
blot
immunis
mice
biosafeti
level
bsl
condit
viru
quantit
infecti
materi
perform
ha
assay
egggrown
viru
plaqu
test
mdck
cell
case
infecti
hpaiv
viru
propag
experi
perform
bsl
laboratori
specif
reaction
gener
mab
test
differ
respiratori
virus
enterovirus
tabl
bacteria
caus
influenzalik
symptom
human
tabl
viru
allanto
fluid
cell
cultur
supernat
inactiv
concentr
ultracentrifug
g
h
c
sucros
cushion
viru
pellet
resuspend
pb
aliquot
store
c
one
aliquot
use
determin
protein
concentr
bcaprotein
assay
thermo
fisher
scientif
schwert
germani
polyclon
rabbit
antiaiv
serum
produc
immunis
rabbit
inactiv
awhoop
swangermani
polyclon
mous
sera
collect
mice
immunis
hybridoma
gener
preimmunis
sera
serv
neg
control
femal
balbc
mice
week
old
immunis
intraperiton
g
awhoop
swangermani
mix
equal
volum
complet
freund
adjuv
sigmaaldrich
chemi
steinheim
germani
follow
booster
immunis
four
week
later
dose
mix
incomplet
freund
adjuv
sigmaaldrich
mice
receiv
three
boost
amount
antigen
pb
day
prior
fusion
spleen
excis
splenocyt
fuse
myeloma
cell
accord
previous
describ
protocol
dorner
et
al
pauli
et
al
begin
day
fusion
hybridoma
supernat
screen
specif
antibodi
threestep
approach
use
initi
screen
hybridoma
supernat
perform
indirect
elisa
follow
select
antibodyproduc
hybridoma
cell
cellelisa
sandwich
assay
mab
purifi
use
hitrap
protein
g
hp
column
ge
healthcar
munich
germani
subsequ
dialys
pb
overnight
dialysi
protein
concentr
determin
use
nanophotomet
tm
uvvi
spectrophotomet
implen
munich
germani
valu
lower
mgml
antibodi
concentr
mean
centrifug
filter
devic
amicon
millipor
corp
bedford
usa
isotyp
purifi
mab
perform
isostrip
mous
monoclon
antibodi
isotyp
kit
rocheappli
scienc
mannheim
germani
specif
sensit
test
purifi
mab
definit
optim
antibodi
pair
indirect
elisa
sandwich
elisa
use
nunc
maxisorb
microtitr
plate
vwr
intern
darmstadt
germani
coat
overnight
c
viral
antigen
gml
pb
neg
control
bsa
ovalbumin
allanto
fluid
l
per
well
block
block
buffer
skim
milk
pb
contain
tween
pbst
l
hybridoma
cultur
supernat
purifi
mab
gml
block
buffer
ad
plate
incub
h
room
temperatur
rt
well
incub
min
rt
l
peroxidaseconjug
goat
antimous
igg
dianova
hamburg
germani
dilut
block
buffer
pbst
wash
perform
three
time
incub
six
time
ad
substrat
use
autom
plate
washer
tecan
crailsheim
germani
bind
antibodi
determin
min
incub
lwell
tetramethylbenzidin
substrat
tmb
dihydrochlorid
tablet
sigmaaldrich
accord
manufactur
instruct
reaction
stop
ad
l
h
absorb
measur
nm
use
autom
plate
reader
tecan
unspecif
crossreact
bacteri
antigen
test
indirect
elisa
use
cfuml
nahco
l
per
well
cellelisa
use
confirm
assay
detect
influenza
virusspecif
hybridoma
cell
supernat
assay
permit
differenti
reaction
antibodi
influenza
viru
cellular
antigen
test
perform
essenti
describ
previous
pauli
et
al
briefli
mdck
cell
cultiv
plate
reach
confluenc
infect
l
viru
pfuml
awhoop
swangermani
incub
h
c
co
fix
formaldehyd
pb
l
hybridoma
cell
supernat
ad
plate
incub
min
c
humid
chamber
wash
five
time
pb
plate
incub
l
hrpconjug
goat
antimous
igg
thermo
fisher
scientif
describ
final
l
freshli
prepar
substrat
solut
mg
sigmaaldrich
chemi
dissolv
ml
dimethylsulphoxid
ad
ml
mm
sodium
acet
buffer
ph
l
h
ad
well
plate
reaction
stop
min
wash
tap
water
analys
light
microscopi
sandwich
assay
use
evalu
abil
mab
function
detector
captur
antibodi
rapid
antigen
detect
system
antigen
captur
assay
b
determin
detect
limit
select
mab
pair
plate
coat
l
appropri
dilut
polyclon
rabbit
antibodi
incub
overnight
c
coat
well
incub
antigen
solut
gml
pb
lwell
h
rt
mab
biotinyl
dilut
block
buffer
accord
elisa
pretest
incub
immobilis
viru
h
rt
final
hrpconjug
streptavidin
block
buffer
dianova
ad
well
process
describ
indirect
elisa
examin
abil
mab
captur
antigen
well
coat
mab
gml
captur
antibodi
polyclon
rabbit
antibodi
use
detector
antibodi
bound
rabbit
antibodi
detect
hrpconjug
goat
antirabbit
igg
dianova
b
captur
mab
dilut
gml
antigen
awhoop
swangermani
appli
serial
dilut
ngml
gml
appropri
dilut
biotinyl
mab
use
detector
antibodi
bind
biotinyl
antibodi
determin
either
via
peroxidaseconjug
streptavidin
sapod
increas
sensit
streptavidin
senova
immunoassay
system
jena
germani
process
describ
viru
prepar
inactiv
subtyp
virus
see
tabl
viru
anew
laemmli
buffer
laemmli
without
boil
min
load
sampl
separ
sdspolyacrylamid
gel
reduc
nonreduc
condit
transfer
onto
polyvinyliden
fluorid
pvdf
membran
biorad
laboratori
munich
germani
membran
submerg
block
buffer
least
min
incub
purifi
mab
dilut
block
buffer
h
rt
wash
extens
pbst
bound
antibodi
detect
incub
min
rt
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
h
l
thermo
fisher
scientif
dilut
block
buffer
final
antibodybind
visualis
use
immunstar
tm
hrp
substrat
kit
biorad
laboratori
follow
exposur
amersham
hyperfilm
ecl
ge
healthcar
confirm
bind
reaction
mab
influenza
viru
ha
protein
viral
glycoprotein
ndeglycosyl
pngase
f
new
england
biolab
inc
frankfurtmain
germani
base
manufactur
instruct
protocol
wagner
et
al
briefli
l
sampl
contain
ng
inactiv
viru
l
denatur
buffer
combin
u
pngase
f
buffer
nonidet
final
reaction
volum
l
incub
h
c
without
denatur
step
c
prior
enzym
treatment
control
treat
similarli
absenc
pngase
f
deglycosyl
reaction
ha
protein
analys
western
blot
nonreduc
condit
describ
mab
primari
antibodi
polyclon
serum
immunis
mous
posit
control
awhoop
swangermani
infect
mdck
cell
mockinfect
cell
mix
incub
microscop
slide
reaction
well
h
incub
time
h
select
prior
experi
differ
incub
time
slide
fix
formaldehyd
pb
store
formaldehyd
c
use
immunofluoresc
stain
slide
incub
purifi
mab
titrat
serial
dilut
gml
sampl
buffer
pb
sodium
azid
bsa
wash
step
slide
incub
fitcconjug
goat
antimous
secondari
antibodi
dianova
final
dilut
wash
slide
cover
mount
medium
investig
fluoresc
microscop
euro
star
ii
euroimmun
germani
control
immunofluoresc
assay
similarli
perform
cell
microtitr
neutralis
mn
assay
use
test
neutralis
capac
mab
first
mab
serial
dilut
gml
ngml
volum
l
mdck
cell
cultur
medium
incub
l
tcid
infecti
viru
awhoop
swangermani
h
c
solut
ad
mdck
cell
monolay
plate
renner
dannstadt
germani
incub
three
day
c
presenc
co
incub
cell
fix
formaldehyd
stain
naphthalen
black
analysi
light
microscop
neutralis
titr
nd
determin
mab
dilut
result
neutralis
infecti
viru
neutralis
effect
determin
mab
serial
dilut
start
mab
concentr
result
neutralis
dilut
test
describ
eight
parallel
cultur
infect
virusmab
mix
nd
calcul
accord
reed
muench
compar
neutralis
effect
mab
differ
strain
concentr
ngml
appli
test
done
triplic
select
mab
highli
specif
antigen
screen
approach
perform
start
hybridoma
clone
reactiv
antigen
immobilis
plastic
surfac
select
use
indirect
elisa
first
screen
round
clone
identifi
react
antigen
prepar
one
except
unspecif
reaction
bsa
allanto
fluid
ovalbumin
detect
independ
second
step
screen
process
cellelisa
test
hybridoma
cell
supernat
use
tool
select
hybridoma
react
virusinfect
cell
elimin
hybridoma
react
cellular
antigen
nonspecif
reaction
cell
protein
occur
fortysix
select
hybridoma
cell
cultur
supernat
evalu
third
screen
step
perform
sandwich
elisa
antibodi
select
capabl
react
antigen
solut
three
screen
procedur
subclon
cultur
hybridoma
cell
clone
obtain
produc
desir
antibodi
characteris
reactiv
specif
select
mab
isol
virus
bacteria
tabl
investig
indirect
elisa
crossreact
influenza
b
n
respiratori
virus
n
bacteria
n
observ
data
shown
reaction
mab
influenza
virus
test
repres
strain
subtyp
n
influenza
subtyp
n
three
differ
test
system
indirect
elisa
sandwich
assay
western
blot
although
mab
show
strong
reactiv
aiv
isol
either
immobilis
solut
test
result
differ
observ
depend
mab
isol
method
use
tabl
indirect
elisa
three
mab
show
strong
reactiv
almost
influenza
ha
subtyp
wherea
mab
demonstr
weak
reaction
ha
subtyp
seven
mab
react
exclus
subtyp
virus
mab
detect
isol
test
except
lpaiv
isol
tabl
evalu
specif
mab
influenza
virus
indirect
elisa
immobilis
antigen
sandwich
elisa
antigen
solut
western
blot
find
mab
combin
abl
detect
isol
extend
sandwich
elisa
studi
conduct
select
mab
alon
mix
two
mab
togeth
use
captur
biotinyl
detector
antibodi
respect
final
sever
pair
mab
identifi
detect
nine
isol
analys
without
crossreact
influenza
subtyp
virus
one
exampl
superior
mab
combin
shown
tabl
evalu
potenti
select
mab
pair
function
rapid
antigen
detect
test
detect
limit
examin
sandwich
elisa
format
gener
underli
principl
later
flow
immunochromatograph
assay
exampl
result
shown
fig
use
peroxidaseconjug
streptavidin
sapod
detect
reagent
limit
detect
ngml
depend
concentr
captur
antibodi
use
improv
detect
limit
ngml
ng
correspond
ha
unit
western
blot
analysi
use
verifi
elisa
result
obtain
reactiv
mab
identifi
antigen
ten
mab
recognis
band
molecular
weight
kda
correspond
ha
protein
purifi
influenza
viru
antibodi
react
exclus
respect
antigen
nonreduc
condit
suggest
mab
target
conform
epitop
interestingli
antibodi
identifi
band
kda
correspond
protein
viru
mab
react
antigen
separ
gel
reduc
nonreduc
condit
impli
mab
target
linear
epitop
within
protein
fig
investig
reactiv
antibodi
influenza
viru
antigen
virus
one
isol
subtyp
caus
crossreact
separ
reduc
nonreduc
condit
probe
differ
mab
six
mab
react
exclus
antigen
wherea
five
mab
identifi
influenza
viru
anew
well
tabl
indic
good
correspond
find
obtain
indirect
elisa
howev
contrast
indirect
elisa
result
six
mab
demonstr
weak
reaction
lpaiv
isol
confirm
bind
reaction
mab
ha
protein
haemagglutinin
deglycosyl
pngase
f
antibodi
polyclon
mous
serum
use
posit
control
detect
ha
protein
western
blot
amount
glycosyl
vari
ha
protein
differ
influenza
viru
isol
deduc
calcul
base
protein
sequenc
alon
use
webbas
applic
calcul
molecular
weight
glycosyl
site
expasi
http
usexpasyorg
expect
shift
ha
band
kda
respect
isol
would
seen
pngase
f
treatment
molecular
weight
ha
protein
reduc
kda
kda
hypothesis
observ
confirm
mab
react
conform
epitop
ha
protein
separ
nonreduc
condit
bind
reaction
antibodi
antigen
affect
deglycosyl
fig
purifi
mab
test
abil
detect
cell
immunofluoresc
tabl
two
mab
react
virusinfect
cell
fix
formaldehyd
awhoop
swangermani
acygnu
olorgermani
two
mab
identifi
neutralis
awhoop
swangermani
mab
tabl
concentr
ngml
mab
ngml
mab
neutralis
tcid
ml
neutralis
assay
anoth
seven
strain
conduct
use
ngml
demonstr
antibodi
broad
neutralis
capac
virus
antibodi
neutralis
eight
strain
test
wherea
mab
neutralis
five
eight
strain
tabl
use
rapid
antigen
detect
test
diagnosi
influenza
associ
predict
valu
thu
highli
depend
sensit
specif
test
system
preval
diseas
popul
petric
et
al
project
initi
grow
demand
improv
commerci
avail
test
kit
diagnost
human
sampl
avail
rapid
antigen
detect
system
either
discrimin
influenza
viru
subtyp
show
low
sensit
lead
test
question
suitabl
routin
applic
clinic
set
chan
et
al
rouleau
et
al
ghebremedhin
et
al
ideal
rapid
antigen
detect
test
would
high
sensit
detect
viru
would
also
abl
differenti
subtyp
chan
et
al
compar
polyclon
antibodi
mab
offer
uniqu
advantag
increas
specif
unlimit
avail
consist
properti
may
exploit
diagnost
applic
yang
et
al
oh
et
al
immunis
strategi
one
import
step
gener
antibodi
detect
nativ
antigen
differ
approach
immunis
mice
influenza
virus
report
immunis
bromelainpurifi
bha
russ
et
al
recombin
antigen
et
al
yang
et
al
formaldehydetr
whole
viru
huang
et
al
immunogen
oh
et
al
known
epitop
viru
fix
formaldehyd
alter
therefor
induc
mab
react
nativ
antigen
determin
duqu
et
al
betapropiolacton
bpl
inactiv
viru
chosen
immunis
use
basi
follow
rational
bpl
preserv
virus
close
nativ
structur
interact
preferenti
viral
genom
wainberg
et
al
surfac
protein
remain
intact
induc
product
mab
linear
conform
epitop
mice
immunis
twice
antigen
prepar
produc
longlast
stabl
titr
furthermor
predict
immunis
whole
virion
would
result
gener
mab
main
surfac
protein
haemagglutinin
fusion
applic
stage
select
system
mab
achiev
target
ha
protein
repres
total
viral
protein
human
influenza
viru
oxford
et
al
one
mab
react
linear
epitop
viral
matrix
protein
protein
associ
inner
membran
virion
investig
gener
mab
reveal
antibodi
recognis
distinct
epitop
rang
specif
immunis
strain
data
shown
conserv
epitop
influenza
virus
virus
bacteria
influenza
recognis
mab
indirect
elisa
major
antibodi
specif
strain
wherea
four
mab
also
react
influenza
viru
subtyp
suggest
bind
conserv
epitop
previou
report
use
elisa
none
four
mab
gener
distinct
isol
detect
virus
isol
isol
use
immunis
oh
et
al
suggest
ha
protein
virus
chang
significantli
sinc
first
isol
viru
year
ago
therefor
mab
direct
recent
virus
bind
earlier
viru
isol
howev
present
studi
reveal
three
antibodi
broader
reaction
pattern
well
five
mab
abl
detect
recent
well
older
isol
eg
thu
assum
stabl
epitop
present
ha
protein
strain
confirm
observ
publish
earlier
et
al
one
except
antibodi
detect
clade
clade
isol
indic
mab
react
broadli
circul
virus
western
blot
analysi
suggest
mab
react
conform
ha
epitop
detect
ha
nonreduc
condit
wherea
one
antibodi
react
protein
detect
linear
epitop
work
reduc
nonreduc
condit
verifi
bind
mab
ha
protein
pngase
f
use
deglycosyl
haemagglutinin
level
glycosyl
ha
protein
vari
significantli
viru
strain
thu
consider
impact
molecular
weight
glycoprotein
harvey
et
al
previou
report
shown
alter
migrat
characterist
deglycosyl
protein
denatur
reduc
condit
harvey
et
al
li
et
al
expect
enzym
treatment
result
smallers
fastermigr
ha
protein
band
shift
kda
kda
demonstr
confirm
gener
mab
detect
exclus
protein
backbon
ha
molecul
furthermor
determin
ectodomain
ha
protein
undergo
conform
chang
viru
prepar
treat
temperatur
c
epand
epand
could
explain
find
mab
react
ha
protein
incub
c
reduc
condit
ha
protein
influenza
viru
target
neutralis
antibodi
former
studi
describ
five
distinct
neutralis
epitop
ha
protein
philpott
et
al
recombin
human
antibodi
influenza
virus
describ
recent
show
neutralis
effect
ticd
virus
antibodi
concentr
gml
gml
depend
clade
sun
et
al
howev
two
antibodi
abl
protect
mdck
cell
infect
treatment
virus
antibodi
concentr
ngml
ngml
respect
result
neutralis
immunis
strain
neutralis
observ
viru
use
immunis
also
isol
test
antibodi
neutralis
virus
clade
wherea
antibodi
react
virus
clade
whether
antibodi
could
use
sourc
product
therapeut
antibodi
yet
seen
purpos
present
investig
develop
mab
could
use
develop
antigen
detect
system
therefor
mab
use
sandwich
elisa
either
captur
detector
antibodi
eight
mab
shown
react
specif
nonimmobilis
antigen
import
applic
sandwichbas
later
flow
assay
gener
good
correl
regard
antibodi
specif
three
immunolog
assay
system
use
differ
epitop
recognit
must
expect
avail
antigen
site
probabl
depend
test
system
use
long
known
antigen
conform
solid
phase
appear
differ
one
solut
vaidya
et
al
one
hand
portion
inject
materi
may
chang
conform
expos
immunogen
site
hidden
nativ
protein
hand
site
expos
nativ
protein
mask
antigen
adsorb
onto
plastic
surfac
vice
versa
mierendorf
dimond
conform
chang
western
blot
denatur
protein
lead
chang
antigen
present
epitop
access
therebi
affect
antigenantibodi
interact
sever
antibodi
gener
abl
recognis
recent
circul
older
virus
immobilis
solut
howev
one
mab
alon
enough
detect
nine
isol
examin
achiev
aim
differ
combin
mab
evalu
use
sandwich
elisa
sever
mab
pair
identifi
detect
virus
analys
without
crossreact
influenza
virus
great
signific
intend
applic
gener
mab
rapid
antigen
detect
system
moreov
establish
combin
mab
result
higher
absorb
read
virus
suggest
combin
mab
direct
differ
epitop
viru
particl
find
agreement
previou
studi
confirm
mab
combin
use
increas
elisa
sensit
et
al
present
studi
demonstr
abil
mab
detect
low
antigen
concentr
make
appropri
develop
enhanc
rapid
antigen
detect
system
accord
instruct
leaflet
avail
test
gener
sensit
ha
importantli
result
establish
sandwich
elisa
show
detect
limit
viru
improv
ha
ngml
indic
potenti
increas
sensit
rapid
antigen
detect
test
furthermor
use
conjug
instead
hrpconjug
streptavidin
detect
limit
significantli
improv
ha
ngml
base
result
expect
applic
newli
gener
mab
rapid
antigen
detect
test
use
conjug
would
result
higher
sensit
assay
comparison
one
current
avail
prospect
studi
perform
test
gener
antibodi
clinic
sampl
verifi
whether
sensit
test
system
might
influenc
sampl
matric
poor
qualiti
sampl
sampl
collect
appropri
may
contain
smaller
amount
viru
thu
associ
lower
sensit
type
transport
media
also
import
compon
may
influenc
sensit
test
addit
dilut
swab
addit
laboratori
test
may
also
lead
neg
rapid
test
result
therefor
author
suggest
use
least
one
nasal
swab
undilut
directli
screen
second
swab
nasal
orand
throat
swab
transport
medium
investig
pcr
viru
cultur
regard
pandem
start
need
rapid
antigen
detect
test
reliabl
result
remain
essenti
system
use
clinic
set
fast
assay
guid
physician
make
best
possibl
clinic
decis
exampl
quarantin
infect
patient
need
follow
clinic
therapeut
monitor
next
clinic
applic
use
rapid
antigen
detect
test
desir
commun
surveil
facil
outbreak
epidemiolog
situat
order
detect
epidemiolog
trend
rouleau
et
al
discuss
rapid
antigen
detect
system
mainli
involv
sensit
specif
recent
evalu
sever
test
method
detect
novel
influenza
confirm
criteria
remain
question
ginocchio
et
al
vasoo
et
al
sambol
et
al
problem
sensit
specif
rapid
antigen
detect
system
remain
whether
pandem
virus
present
therefor
need
better
assay
essenti
far
world
health
organ
recommend
routin
use
rapid
test
alon
surveil
purpos
patient
manag
without
confirmatori
test
paper
describ
gener
highli
specif
mab
virus
might
use
tool
develop
rapid
diagnost
system
mab
produc
appli
varieti
immunoassay
pointofcar
test
ai
infect
base
elisa
result
newli
produc
mab
mab
combin
establish
appropri
improv
avail
rapid
antigen
detect
system
diagnosi
infect
area
specif
sensit
studi
way
implement
novel
antibodi
differ
test
platform
compet
interest
studi
support
grant
german
govern
forschungssofortprogramm
influenza
de
bund
fsi
